FDA NDC Directory · JSON-LD · Markdown

Deferoxamine mesylate

NDC 68083-173 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Labeler / ManufacturerGland Pharma Limited
Marketing categoryAbbreviated NDA (generic) · App ANDA207384
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS
Active ingredientsDEFEROXAMINE MESYLATE (2 g/1)
Marketing started20171009
Package count1

External sources

Source: openFDA. Public-domain (CC0).